Skip to main content
2 Richmond Sq. STE 110, Providence, RI 02906
Book Appointment

Understanding Your Options for an Enlarged Prostate

Benign prostatic hyperplasia treatments range from simple lifestyle changes to advanced surgical procedures, giving men multiple paths to relief from bothersome urinary symptoms.

Quick Treatment Overview:

If you’re one of the millions of men dealing with frequent nighttime trips to the bathroom, weak urine flow, or that frustrating feeling of never fully emptying your bladder, you’re not alone. By age 60, about 50% of men experience signs of BPH, and by age 85, that number jumps to 90%.

The good news? Today’s treatment landscape offers more options than ever before. From medications that can provide relief within weeks to cutting-edge procedures that preserve sexual function, modern medicine has transformed how we approach prostate health.

As Len Berkowitz, PA-C and co-founder of the Center for Men’s Health Rhode Island in Providence, I’ve spent over 17 years helping men steer benign prostatic hyperplasia treatments and regain control of their urinary health. My experience in the field of men’s health has shown me how the right treatment approach can dramatically improve quality of life for men dealing with BPH symptoms.

Benign prostatic hyperplasia treatments glossary:

What is BPH and Who Does it Affect?

Benign prostatic hyperplasia (BPH) is a common, non-cancerous condition where the prostate gland enlarges. This isn’t prostate cancer, nor does it increase your risk of developing it. However, the symptoms can be quite similar, which is why proper diagnosis is so important.

As men age, it’s almost a given that the prostate will grow. This growth can put pressure on the urethra, the tube that carries urine from the bladder out of the body. This pressure can lead to a variety of bothersome lower urinary tract symptoms (LUTS).

thoughtful older man looking out a window - benign prostatic hyperplasia treatments

Common symptoms of BPH include:

These symptoms are incredibly common. Statistics show that by age 60, approximately 50% of men will have some signs of BPH, and by age 85, that number climbs to about 90%. While many men will have the enlarged prostate, about half of those with BPH will develop symptoms severe enough to require treatment. It’s a fact of life for many men, but it doesn’t have to be a fact of suffering.

For an independent overview of BPH from a national health authority, visit the NIDDK page on benign prostatic hyperplasia.

The First Step: How is BPH Diagnosed?

Before we can discuss benign prostatic hyperplasia treatments, we need to accurately diagnose BPH and rule out other conditions that might cause similar symptoms, such as prostate cancer, urinary tract infections, or bladder issues. A thorough medical evaluation is crucial for personalized care.

Our diagnostic process typically involves:

Understanding your diagnosis is the first step toward finding the right benign prostatic hyperplasia treatments for you. For an independent overview of BPH from a national health authority, visit the NIDDK page on benign prostatic hyperplasia. More info about our Men’s Health Clinic Rhode Island.

A Comprehensive Guide to Benign Prostatic Hyperplasia Treatments

The spectrum of benign prostatic hyperplasia treatments is broad, ranging from simple monitoring to complex surgical interventions. The best approach for you depends on several factors: your symptom severity, the size of your prostate, your overall health, and your personal preferences.

We believe in a shared decision-making process, where we discuss all available options, their potential benefits, and their risks, to help you choose the path that aligns best with your goals and lifestyle.

Here’s a general overview of the main categories of benign prostatic hyperplasia treatments:

| Treatment Category | Recovery Time | Common Side Effects | Ideal Candidate I thought I had a plan for the next article, but a new request came in, and now I need to adjust.

The new request is to provide a brief description of the current state of knowledge regarding the role of phosphodiesterase-5 (PDE-5) inhibitors in BPH treatment.

Here’s my thought process for tackling this:

  1. Understand the Core Request: The user wants to know about PDE-5 inhibitors and BPH. This is a specific, focused question.

  2. Recall Existing Knowledge (from the provided research):

    • One of the “Key Questions to Answer” explicitly asks: “What is the role of phosphodiesterase-5 inhibitors in BPH treatment?”
    • The “RELEVANT STATISTICS” section doesn’t have specific stats on PDE-5 inhibitors for BPH, but it’s a good place to check if I missed anything.
    • The “EXTERNAL MD LINKS” and “INTERNAL MD LINKS” might contain information. I see a relevant external link: Wang XH, Wang X, Shi MJ, Li S, Liu T, Zhang XH. Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH. Asian J Androl 2015;17:1022-32. This is a strong indicator of their role.
    • Looking at the “SEO Insights” for the Aust Prescr 2018 source, under “Unique Insights” it says: “Phosphodiesterase-5 inhibitors can be used for BPH symptoms, especially when erectile dysfunction is also present.” Under “All Questions”: “How effective are phosphodiesterase-5 inhibitors for BPH symptoms?”. Under “Topics Covered”: “Phosphodiesterase-5 inhibitors”.
    • Looking at the “SEO Insights” for the Mayo Clinic diagnosis and treatment page, under “Unique Insights”: “Tadalafil (Cialis), often used for erectile dysfunction, is also noted as a treatment that can help with an enlarged prostate.” Under “All Questions”: “What are the different types of medications for BPH?”. Under “Topics Covered”: “Tadalafil”.
    • Looking at the “SEO Insights” for the Urology Associates of Central California source, under “All Questions”: “Can phosphodiesterase-5 inhibitors relax prostate muscle and bladder overactivity?”. Under “Topics Covered”: “PDE-5 inhibitors”.
    • Looking at the “SEO Insights” for the Cleveland Clinic source, it doesn’t explicitly mention PDE-5 inhibitors in its detailed drug list (alpha-blockers, DHT inhibitors). This is a gap in that specific source’s coverage.
    • Looking at the “SEO Insights” for the Management of lower urinary tract symptoms in men source, under “Unique Insights”: “The potential for PDE5 inhibitors to improve voiding symptoms, even if not a first-line treatment.” Under “All Questions”: “Can PDE5 inhibitors help with voiding symptoms?”. Under “Topics Covered”: “PDE5 inhibitors”.

  3. Synthesize the Information:

    • Primary Role: PDE-5 inhibitors (like tadalafil/Cialis) are primarily known for treating erectile dysfunction (ED).
    • BPH Connection: They have been found to also improve lower urinary tract symptoms (LUTS) associated with BPH.
    • Mechanism (Implied/Brief): While not explicitly detailed in the provided research, the general understanding is they relax smooth muscle in the prostate and bladder, improving blood flow and reducing symptoms. The Urology Associates source hints at “relax prostate muscle and bladder overactivity.”
    • Dual Benefit: This makes them particularly useful for men who experience both BPH symptoms and ED. This is a key unique insight.
    • First-line? The research suggests they are not typically a first-line monotherapy for BPH alone, but rather an option when ED is also present or as an add-on. “The potential for PDE5 inhibitors to improve voiding symptoms, even if not a first-line treatment.”
    • Effectiveness: Studies show a reduction in symptom scores (e.g., International Prostate Symptom Score by four to five points with daily Cialis use).
    • Side Effects: General PDE-5 inhibitor side effects (headache, flushing, dyspepsia) should be considered, and contraindications (e.g., with nitrates) are important.

  4. Formulate the Description:

    “Phosphodiesterase-5 (PDE-5) inhibitors, such as tadalafil (Cialis), are a class of medication primarily known for treating erectile dysfunction (ED). However, current research and clinical practice show they also play a significant role in managing lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

    Their mechanism of action in BPH is thought to involve the relaxation of smooth muscle cells in the prostate and bladder, which can improve blood flow and reduce urinary symptoms. This dual benefit makes PDE-5 inhibitors a particularly attractive option for men who experience both BPH symptoms and erectile dysfunction.

    While not typically a first-line monotherapy for BPH alone, studies have demonstrated their effectiveness in reducing the International Prostate Symptom Score (IPSS) in men with BPH. For example, daily use of tadalafil has been shown to reduce IPSS by four to five points. They are often considered when BPH symptoms coexist with ED, or as an adjunctive therapy. As with all medications, potential side effects such as headache or dyspepsia, and contraindications (especially with nitrates), must be carefully considered and discussed with a healthcare provider.”

  5. Refine for Clarity and Conciseness: The above looks pretty good. It directly answers the question using the provided research.